Supplemental material
Acta Oncologica
Volume 58, 2019 - Issue 1
Open access
2,631
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: RADIOTHERAPY AND RADIOBIOLOGY
Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial
Daniëlle B. P. EekersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; ;Proton Therapy Centre South-East Netherlands (ZON-PTC), Maastricht, The Netherlands; Correspondence[email protected]
, Erik RoelofsDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; ;Department of Radiation Oncology (The D-Lab), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;
, Macarena Cubillos-MesíasOncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Cal Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany;
, Charles NiëlDepartment of Radiation Oncology, Radiotherapiegroep, Deventer, The Netherlands;
, Robert Jan SmeenkDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands;
, Ann HoebenDepartment of Medical Oncology, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;
, Andre W. H. MinkenDepartment of Radiation Oncology, Radiotherapiegroep, Deventer, The Netherlands;
, Marlies GranzierDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;
, Geert O. JanssensDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands; ;Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; ;Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands;
, Johannes H. A. M. KaandersDepartment of Radiation Oncology, RadboudUMC, Nijmegen, The Netherlands;
, Philippe LambinDepartment of Radiation Oncology (The D-Lab), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands;
& Esther G. C. TroostOncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Cal Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany; ;Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; ;Helmholtz-Zentrum Dresden – Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany; ;German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; ;National Center for Tumor Diseases (NCT) Partner Site Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden, Rossendorf (HZDR), Dresden, Germany
show all
Pages 57-65
|
Received 01 Jun 2018, Accepted 22 Sep 2018, Published online: 26 Nov 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.